tirzepatide phase 1 on ingestive behavior in adults with overweight or obesity: a randomized 6-week trial What to Expect on Tirzepatide:

In Zulassungsstudien 1,2 wurden unter Liraglutid nach 56 Wochen durchschnittliche Gewichtsreduktionen von etwa 8 % des Ausgangsgewichts und unter Semaglutid nach 68 Wochen von etwa 15 % des Ausgangsgewichts beobachtet

Although to a lesser extent than cholestyramine, colestipol also has been shown to inhibit the GI absorption and therapeutic response of thiazide diuretics

Side Effects Both medications carry similar side effects, with gastrointestinal issues being the most common

The reconstitution calculator handles this optimization automatically, letting you input your target units and vial size to get the optimal water volume

Weight returns when the drug stops In the STEP 1 extension, patients regained roughly two-thirds of the weight they had lost within a year of stopping semaglutide